Paper Details
- Home
- Paper Details
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.
Author: Adamah-BiassiEkue B, CloughShannon J, DubocovichMargarita L, HutchinsonAnthony J, LiuJiabei, Popovska-GorevskiMarina
Original Abstract of the Article :
Melatonin, or 5-methoxy-N-acetyltryptamine, is synthesized and released by the pineal gland and locally in the retina following a circadian rhythm, with low levels during the day and elevated levels at night. Melatonin activates two high-affinity G protein-coupled receptors, termed MT1 and MT2, to e...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/26514204
データ提供:米国国立医学図書館(NLM)
Melatonin Receptors: A New Pathway for Treating Sleep Disorders and Beyond
Melatonin, a hormone produced by the pineal gland, plays a crucial role in regulating sleep-wake cycles and other physiological processes. This research delves into the therapeutic potential of melatonin receptors, MT1 and MT2, in treating a range of conditions, including sleep disorders, mood disorders, and cancer. The authors discuss the pharmacological properties of melatonin agonists, highlighting their potential for treating insomnia, circadian rhythm abnormalities, and other health challenges. The study emphasizes the importance of understanding the specific roles of MT1 and MT2 receptors in mediating melatonin's effects, paving the way for the development of novel and more effective therapeutic agents. This research underscores the growing understanding of melatonin's role in health and disease, opening new avenues for therapeutic interventions.
Melatonin Receptors: A Gateway to Improved Sleep and Well-being
The desert of sleep disorders can be a challenging landscape to navigate, with its shifting sands of insomnia and restless nights. This research explores the potential of melatonin receptors, MT1 and MT2, as a gateway to improved sleep and well-being. The study highlights the potential of melatonin agonists for treating insomnia and circadian rhythm abnormalities, suggesting a new path toward better sleep and improved quality of life. It's a reminder that the desert of sleep research is a fertile ground for innovation, with new discoveries constantly emerging to address the challenges of sleep disorders.
Navigating the Desert of Sleep Disorders: Melatonin's Potential
The desert of sleep disorders can be a daunting landscape to traverse, with its complexities and uncertainties. This research provides a glimpse into the potential of melatonin receptors as a beacon of hope for those seeking relief from insomnia and other sleep disturbances. It's a reminder that the desert of sleep research is a dynamic one, with ongoing efforts to understand the role of melatonin in regulating sleep and develop new and effective treatments for those navigating the challenges of sleep disorders.
Dr.Camel's Conclusion
This research delves into the therapeutic potential of melatonin receptors, MT1 and MT2, offering a glimpse into a new oasis of hope for those struggling with sleep disorders, mood disorders, and even cancer. It's a reminder that the desert of scientific discovery is constantly evolving, with new insights and potential treatments emerging to address the challenges of human health.
Date :
- Date Completed 2016-09-30
- Date Revised 2023-07-27
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.